PS1:22 Use of interferon alpha and interleukin-10 as clinical activity biomarkers in systemic lupus erythematous patients

Abstract

investigate and visualise characteristic marker prevalence and coprevalence patterns. Results Based on the individual marker pattern, patients can often be stratified belonging to different study subgroups. For example, for SLE we show that different reactivity groups exist including patients with different disease activity scores and organ damage patterns. Conclusions We conclude that the approach of a comprehensive prevalence and signature analysis and a vivid data visualisation is useful for any multiplex omics assay.